Koivisto, A.J.; Altin, M.; Furxhi, I.; Eliat, M.; Trabucco, S.; Blosi, M.; Lopez de Ipiña, J.; Belosi, F.; Costa, A.
Burden of Disease (BoD) Assessment to Estimate Risk Factors Impact in a Real Nanomanufacturing Scenario. Nanomaterials 2022, 12, 4089.
https://doi.org/10.3390/nano12224089
AMA Style
Koivisto AJ, Altin M, Furxhi I, Eliat M, Trabucco S, Blosi M, Lopez de Ipiña J, Belosi F, Costa A.
Burden of Disease (BoD) Assessment to Estimate Risk Factors Impact in a Real Nanomanufacturing Scenario. Nanomaterials. 2022; 12(22):4089.
https://doi.org/10.3390/nano12224089
Chicago/Turabian Style
Koivisto, Antti Joonas, Marko Altin, Irini Furxhi, Maxime Eliat, Sara Trabucco, Magda Blosi, Jesús Lopez de Ipiña, Franco Belosi, and Anna Costa.
2022. "Burden of Disease (BoD) Assessment to Estimate Risk Factors Impact in a Real Nanomanufacturing Scenario" Nanomaterials 12, no. 22: 4089.
https://doi.org/10.3390/nano12224089
APA Style
Koivisto, A. J., Altin, M., Furxhi, I., Eliat, M., Trabucco, S., Blosi, M., Lopez de Ipiña, J., Belosi, F., & Costa, A.
(2022). Burden of Disease (BoD) Assessment to Estimate Risk Factors Impact in a Real Nanomanufacturing Scenario. Nanomaterials, 12(22), 4089.
https://doi.org/10.3390/nano12224089